We have a newly created opportunity within the Finance team for an experienced Management Accountant (internally known at Takeda as UK Planning and Reporting Controller).  The role reports to our MCO UK & Ireland Business Controller, and will have key accountabilities for leading on the UK and Ireland Reporting and Planning Process.

The successful candidate will ideally have a minimum of 5 years relevant experience within a commercial environment, ideally within the pharmaceutical sector and be ACCA/ CIMA Finalist or Qualified. Sound commercial awareness with a thorough grasp on all aspects of the role responsibilities and external financial reporting requirements is essential.

The candidate must demonstrate strong finance system skills (preferably SAP) and the motivation to drive improvement of existing systems. This role requires communication at all levels across the business on multiple projects and therefore would suit an adaptable professional with a customer focussed and collaborative working style.

This is a diverse and varied role with responsibilities to include:

  • Month end accountabilities – including reporting for UK, production of timely and accurate financial reporting and analysis, profitability analysis, and generation of accruals and prepayments
  • Reporting and analysis of variances and the implications on the business
  • Assisting HR in monthly and annual payroll activity and other monthly P&L analysis
  •  Management of SAP system and ensuring accurate records in relation to fixed assets
  • Training of non-finance personnel with regards to financial systems and processes ensuring compliance and accuracy of reporting.

 
This high profile role offers a proactive and results orientated finance professional the opportunity to work closely with the UK commercial business and also with our European Country affiliates and shared service centre.

Applicants should apply on-line via www.takedajobs.com or contact HR Consultant Cally Howarth (cally@halo-life.co.uk, 07880 500917).

 

 

Date of Preparation: August 2017

 

Takeda Pharma